Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.38 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.37 |
| ▸ | CPT2 | P23786 | 4/20 | 0.37 |
| ▸ | CPT1A | P50416 | 4/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | CPT1B | Q92523 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.35 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL716616 | 0.91 | CPT2 (0.38) | TRPV1BAZ2ACPT2CPT1APOLB | |
| SCHEMBL166998 | 0.84 | TRPV1 (0.43) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL166997 | 0.84 | TRPV1 (0.43) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL174021 | 0.83 | TRPV1 (0.40) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL6466401 | 0.82 | TRPV1 (0.40) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL2713636 | 0.82 | TRPV1 (0.40) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL6468509 | 0.82 | TRPV1 (0.40) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL7872430 | 0.82 | TRPV1 (0.45) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL475428 | 0.82 | TRPV1 (0.45) | NAA50TRPV1BAZ2ACPT2CPT1A | |
| SCHEMBL6466508 | 0.82 | TRPV1 (0.40) | NAA50TRPV1BAZ2ACPT2CPT1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120053200-A1 | BACE 2 INHIBITORS | HOFFMANN-LA ROCHE INC. | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053200-A1 | BACE 2 INHIBITORS | BACE2, BACE1, PSEN2 | NAA50 1309/4885TRPV1 2871/4885BAZ2A 708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.